Patents Assigned to EndoSAT NV
  • Patent number: 10201565
    Abstract: A method for reducing or preventing mesothelial cell damage by mixing a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N2O) to form a medicament and applying the medicament during surgery. The method can be used for prevention of adhesion formation, pain reduction, reducing or preventing acute inflammation, reducing or preventing CO2 resorbtion or reducing tumor cell implantation upon surgery.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: February 12, 2019
    Assignee: ENDOSAT NV
    Inventors: Karina Mailova, Leila Adamyan
  • Publication number: 20180071332
    Abstract: A method for reducing or preventing mesothelial cell damage by mixing a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N2O) to form a medicament and applying the medicament during surgery. The method can be used for prevention of adhesion formation, pain reduction, reducing or preventing acute inflammation, reducing or preventing CO2 resorbtion or reducing tumor cell implantation upon surgery.
    Type: Application
    Filed: September 25, 2017
    Publication date: March 15, 2018
    Applicant: EndoSAT NV
    Inventors: Karina MAILOVA, Leila ADAMYAN
  • Patent number: 9402863
    Abstract: A method for preventing mesothelial cell trauma is described. The method comprises applying at pool of conditioning techniques prior and/or during surgery for decreasing detrimental factors and optimally using beneficial factors. The pool of conditioning techniques thereby comprises at least applying an irrigation liquid to irrigate at least part of the area of surgery wherein the irrigation liquid is a pH buffering liquid.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: August 2, 2016
    Assignee: ENDOSAT NV
    Inventors: Karina Mailova, Leila Adamyan
  • Publication number: 20150174159
    Abstract: A method for reducing or preventing mesothelial cell damage by mixing a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N2O) to form a medicament and applying the medicament during surgery. The method can be used for prevention of adhesion formation, pain reduction, reducing or preventing acute inflammation, reducing or preventing CO2 resorbtion or reducing tumor cell implantation upon surgery.
    Type: Application
    Filed: March 4, 2015
    Publication date: June 25, 2015
    Applicant: EndoSAT NV
    Inventors: Karina MAILOVA, Leila ADAMYAN